Webinars for Researchers

Centering Equity and Inclusion to Advance PD Therapeutic Development

Tuesday, September 14, 11 a.m. ET

This webinar will highlight evolving initiatives — including those compiling genetic insights from diverse global cohorts — that can provide a more complete understanding of Parkinson's disease and fuel novel avenues for therapeutic development.

In an online meeting, principal investigator of the Parkinson’s Progression Markers Initiative, Ken Marek, MD, discussed the landmark study’s methods, data and analysis. PPMI data is available to qualified researchers at www.ppmi-info.org.  

Learn how to register for the Fox Data Exploration Network (Fox DEN) data platform and then define cohorts and perform analyses within it. This platform contains data from our online Fox Insight study.

MJFF funded the collaborative Foundational Data Initiative for Parkinson's Disease (FOUNDIN-PD) to generate omics data from induced pluripotent stem cell (iPSC) lines from our Parkinson’s Progression Markers Initiative. All FOUNDIN-PD data is publicly available. Watch a webinar to hear the project’s latest findings and analysis plans. 

This webinar covers our funding program to support work toward alpha-synuclein seed amplification assays. Learn more about this program.

Part of our Parkinson's Disease Therapeutics Webinars series, our panel discusses clinical heterogeneity in Parkinson’s disease; using genetic, biologic and pathologic signatures for designing clinical trials; and precision medicine approaches for Parkinson’s in this February 2021 event.  

Part of our Parkinson's Disease Therapeutics Webinars series, this June 2021 event focuses on approaches to engaging Parkinson’s patients, care partners and advocates as another critical set of experts that can help guide development of better treatments.

GP2, a resource of the Aligning Science Across Parkinson's (ASAP) initiative, offers free training in Parkinson's genetics tools and topics for all levels of expertise. Fill out a form on the GP2 site to access courses including:

• Parkinson's Disease Genetics for Non-Geneticists

• Beginner Bioinformatics for Parkinson’s Disease Genetics

• Using Terra to Access Data & Perform Analyses

This March 2021 webinar provides an overview of the Promoting Diversity, Equity and Inclusion in Parkinson's Disease Research request for applications (RFA) as well as of our MJFF funding strategy

Hear panelists present the goals of the Aligning Science Across Parkinson's (ASAP) initiative. This October 2020 recording also covers a funding opportunity focused on research into circuitry and brain-body interactions.

This virtual program provides an overview of common Parkinson’s-related genetic mutations and focuses on the implications of recent discoveries on patient clinical care and clinical research; existing mechanisms for genotyping of PD patients (including direct to consumer, research and commercial testing); the role of genetic counseling; and ethical issues surrounding genetic testing of the PD manifest and at-risk individuals.

This is a two-part course called Clinical Genetic Testing for Parkinson’s Disease: Why, When and How? A Virtual CME Series, sponsored by MJFF and Northwestern University.

This webinar provides an overview of The Michael J. Fox Foundation's funding strategy, our current funding opportunities, and the grant application and review processes.

In 2020 our Parkinson's Disease Therapeutics Webinars series held the following events:

• Where We Are & Where We Are Heading: A Look Ahead at Therapeutic Development in Parkinson’s
• The Many Faces of Parkinson's
• Molecular Signatures of Parkinson’s Disease
• Patient-Focused Drug Development: Novel Instruments to Capture Patient Outcomes in Parkinson’s